Aim: Mutated transthyretin (TTRv) cardiac amyloidosis (CA) represents an uncommon form of CA. Our study aimed to assess the best echocardiographic prognostic parameter in the early stage of TTRv amyloidosis with cardiomyopathy.Methods: In total, 99 patients with TTRv in New York Heart Association class I or II and with no clinical history of previous cardiac disease were studied. Assessment with 99mTc-DPD whole-body scan showed CA in 46 patients. At the first medical contact, an echocardiographic examination was performed. In addition to conventional left ventricular (LV), echocardiographic measurements [ejection fraction (EF), dimensions and diastolic function, global longitudinal strain (GLS), longitudinal strain of the 4 apical segments,...
Abstract Amyloid transthyretin (ATTR) depositions cause left ventricular (LV) hypertrophy, diastolic...
Primary light-chain (AL) amyloidosis is a plasma cell dyscrasia associated with the deposition of im...
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is today more frequently recognized but the ...
Background - : Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse ...
BACKGROUND: Few studies have analyzed the clinical and echocardiographic differences between light-c...
Background: Mutated transthyretin-associated (ATTRm) amyloidosis with heart failure is associated wi...
Objectives: The aim of this study was to characterize left atrial (LA) pathology in explanted hearts...
AbstractBackgroundMutated transthyretin-associated (ATTRm) amyloidosis with heart failure is associa...
Abstract Background: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellu...
BACKGROUND: Management of cardiac amyloidosis (CA) is related to amyloid deposition. Our aim was to ...
Background: Cardiac amyloidosis (CA) is cardiomyopathy with a hypertrophic phenotype characterised b...
Systemic amyloidoses are rare and proteiform diseases, caused by extracellular accumulation of insol...
Cardiac amyloidosis (CA) is of poor prognosis and has three main causes: light chain (AL), hereditar...
BACKGROUND: Prognosis in light-chain (AL) and transthyretin (ATTR) amyloidosis is influenced by card...
Background: The extent of right ventricular (RV) involvement in transthyretin amyloidosis (ATTR) is ...
Abstract Amyloid transthyretin (ATTR) depositions cause left ventricular (LV) hypertrophy, diastolic...
Primary light-chain (AL) amyloidosis is a plasma cell dyscrasia associated with the deposition of im...
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is today more frequently recognized but the ...
Background - : Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse ...
BACKGROUND: Few studies have analyzed the clinical and echocardiographic differences between light-c...
Background: Mutated transthyretin-associated (ATTRm) amyloidosis with heart failure is associated wi...
Objectives: The aim of this study was to characterize left atrial (LA) pathology in explanted hearts...
AbstractBackgroundMutated transthyretin-associated (ATTRm) amyloidosis with heart failure is associa...
Abstract Background: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellu...
BACKGROUND: Management of cardiac amyloidosis (CA) is related to amyloid deposition. Our aim was to ...
Background: Cardiac amyloidosis (CA) is cardiomyopathy with a hypertrophic phenotype characterised b...
Systemic amyloidoses are rare and proteiform diseases, caused by extracellular accumulation of insol...
Cardiac amyloidosis (CA) is of poor prognosis and has three main causes: light chain (AL), hereditar...
BACKGROUND: Prognosis in light-chain (AL) and transthyretin (ATTR) amyloidosis is influenced by card...
Background: The extent of right ventricular (RV) involvement in transthyretin amyloidosis (ATTR) is ...
Abstract Amyloid transthyretin (ATTR) depositions cause left ventricular (LV) hypertrophy, diastolic...
Primary light-chain (AL) amyloidosis is a plasma cell dyscrasia associated with the deposition of im...
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is today more frequently recognized but the ...